Evolution of 'The guideline advantage': Lessons learned from the front lines ofoutpatient performance measurement

摘要

Heart disease, cancer, stroke, and diabetes mellitus collectively account for >1.37 million U.S. deaths each year (1). Compounding the tragedy is the knowledge that many of those deaths could be avoided through better application of clinical guidelines related to primary and secondary prevention or disease management. The combined control of blood pressure, lipids, and glucose has been shown to substantially reduce mortality and cardiovascular events (2,3). Screening for colon, cervical, breast, and lung cancer has been proven to reduce age-adjusted mortality from these diseases (4). In recognition of the common risk factors across these disease areas, the chief executive officers of the American Cancer Society, American Diabetes Association, and American Heart Association formed the Preventive Health Partnership in 2004. The 3 organizations have been working closely ever since to increase public awareness about healthy lifestyles, support policies that increase funding for and access to prevention programs and research, and increase the focus on prevention among healthcare providers.